首页> 外文期刊>Journal of Drug Delivery and Therapeutics >THE Formulation and In-vitro evaluation of press coated tablets of pravastatin for pulsatile drug delivery
【24h】

THE Formulation and In-vitro evaluation of press coated tablets of pravastatin for pulsatile drug delivery

机译:普伐他汀用于脉冲药物递送的压制包衣片剂的配方和体外评价

获取原文
           

摘要

The aim of present study is to formulate and evaluate Pravastatin pulsatile drug delivery system by press coated method to mimic the circadian rhythm of the disease by releasing the drug with a distinct predetermined lag time of 6 hrs. The basic design of the system consists of a rapid release core and controlled release coat. Core blend was evaluated for flow properties, hardness, thickness, friability and invitro drug release. Invitro drug release studies of press coated tablets for various formulations i.e., P1F6-P5F6 was conducted. From the results obtained by executed trails P5F6 of coated tablet containing 50% of ethyl cellulose and 20% of HPMC K15M concentration shows lag time up to 6hr and followed by complete drug release at the end of 8hr. Among these, P5F6 was considered as optimized formulation based on the lag time and percent of drug release (98.96% of drug release in 6 hrs). So, it is selected as optimized formulations for designing pulsatile device.
机译:本研究的目的是通过加压包衣方法来配制和评估普伐他汀脉冲药物递送系统,以通过以预定的6小时明显的延迟时间释放药物来模拟疾病的昼夜节律。该系统的基本设计包括快速释放核心和控释包衣。评价核心混合物的流动性,硬度,厚度,脆性和体外药物释放。对各种制剂即P1F6-P5F6的压制包衣片剂进行了体外药物释放研究。从通过执行的轨迹得到的结果中,含有50%乙基纤维素和20%HPMC K15M浓度的包衣片剂的P5F6显示出滞后时间长达6小时,然后在8小时结束时完全释放药物。其中,根据滞后时间和药物释放百分比(6小时内药物释放的98.96%),P5F6被认为是优化的制剂。因此,选择它作为设计脉动装置的优化配方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号